A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models

Photo-immunotherapy uses antibodies conjugated to Pet Barrier photosensitizers to produce nanostructured constructs endowed with targeting properties and photo-inactivation capabilities towards tumor cells.The superficial receptor density on cancer cells is considered a determining factor for the efficacy of the photodynamic treatment.In this work,

read more